pipeline image

Product pipeline

Our system enables clinicians to apply thermotherapy treatment to the precise site of the tumour.

The Focuscore produces the microwaves. The Focuscore can be connected to different body site applicators, which antennas are directing the microwaves to the tumour sites.

The first applicator is used for the treatment of Head and Neck Cancer. A prototype is already in use in Erasmus MC (Rotterdam, NL). The prototype is now in the transition to a commercial product. We aim for market launch in 2025.

The second applicator is for the treatment of intact breast cancer.

Many Tumor Treatments in Pipeline

Head and Neck Cancer (HNC): Initial Launch

  • Highly underserved, poor survival
  • Technically most challenging: proof for other tumor types
  • Leveraging experience from Erasmus MC (70+ patients treated)

Expansion to other solid tumors:

  • FocusCup – breast cancer w/ Chemotherapy
  • FocusBlanket – melanoma w/ Immunotherapy
  • FocusExtremity – sarcoma w/ Chemotherapy
Sensius products are in development and are not yet for sale.
pipeline image

Currently, Sensius’ Focus product family consists of different components

Screenshot 2021 11 25 at 15 v2.34.59


A a base unit which comprises all components which are needed for treatment of all type of tumours (including a height-adjustable bed, twenty independently controlled microwave amplifiers, water pumps and cooling, a nurse station and control computers). No extra room is needed for the amplifiers.

Screenshot 2021 11 25 at 15.34.49


A body-site specific add-on to our FocusCore to position antennas around the target area and connect the energy to the body via a body-site specific bolus, such as the FocusCollar for head and neck cancer.

Screenshot 2021 11 25 at 15.35.52


A software providing accurate treatment preparation and delivery, customized to individual patient. Based on our WaveAdaptstm patented technology.

AdobeStock 49610871


Potential use in breast cancer.

AdobeStock 61708702


Potential use in melanoma.

AdobeStock 440616170


Potential use in sarcoma (arms and legs).